Target intelligence / Profile preview

Voltage-dependent anion channel 1 (VDAC1) (VDAC1)

Target
VDAC1
Molecular classification
Ion channel, Receptor, Other
01

Overview

Voltage-dependent anion channel 1 (VDAC1) has been identified as a key host cell surface receptor mediating the entry of Newcastle Disease Virus (NDV), including the highly virulent Italien strain (PubMed). While NDV initially attaches to sialic acid-containing glycoconjugates via its Hemagglutinin-Neuraminidase (HN) protein, the subsequent interaction with VDAC1 is crucial for viral internalisation and infection (PubMed). VDAC1 is a pore-forming protein primarily known for its role in the outer mitochondrial membrane, where it regulates the exchange of metabolites and ions between the mitochondria and the cytosol (UniProt). However, its presence on the plasma membrane allows it to serve as a gateway for certain viruses. The Italien strain, a velogenic form of NDV, causes severe respiratory and neurological disease in poultry, making the HN-VDAC1 interaction a significant target for antiviral development (NCBI). Experimental inhibitors like VBIT-4, which target VDAC1, have demonstrated the ability to block NDV entry, although the protein's essential role in cellular metabolism and apoptosis presents challenges for systemic therapeutic use (PubMed).

Other names
Outer mitochondrial membrane protein porin 1Plasmalemmal porinVDAC-1Sialic acid receptorNewcastle disease virus receptor
02

Mechanism of action

Inhibition of VDAC1 prevents its interaction with the viral Hemagglutinin-Neuraminidase (HN) protein, thereby blocking viral entry; alternatively, sialidases remove the primary attachment factor, sialic acid, to prevent viral binding.

03

Biological functions

ApoptosisMetabolismViral entryImmune response
04

Disease associations

InfectionCancerNeurodegenerative disease
05

Safety considerations

Potential for mitochondrial toxicityDisruption of cellular energy metabolismOff-target effects due to ubiquitous expression
06

Interacting drugs

VBIT-4

4 more in the full profile.

07

Biomarkers

VDAC1 expression levelSialic acid expression level

Beyond the preview

Go deeper on Voltage-dependent anion channel 1 (VDAC1) (VDAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion channel 1 (VDAC1) (VDAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call